$BTAI

BioXcel Therapeutics Inc

  • NASDAQ
  • Health Technology
  • Biotechnology
  • Manufacturing
  • Pharmaceutical Preparation Manufacturing

PRICE

$12.44 ▲1.551%

Extented Hours

VOLUME

574,683

DAY RANGE

11.25 - 12.75

52 WEEK

9.08 - 39

Join Discuss about BTAI with like-minded investors

profile
@DarkPoolAlgo #Dark Pool Charts
recently

Thursday, September 16, 2021 U.S. futures are pointing to a lower open, pulling back ahead of weekly jobless claims and retail sales data (economists are looking for a 0.8% drop in retail sales for August, compared with a 1.1% fall the month) while Asian markets fell for a 4th straight day following China’s broadening crackdown on corporate profitability. In Asian markets, The Nikkei Index fell -188 points to 30,323, the Shanghai Index dropped -49 points (1.34%) to 3,607 and the Hang Seng Index tumbled -365 points to 24,667. In Europe, the German DAX is up about 75 points to 15,690, while the FTSE 100 is higher by 30-points to 7,050. Oil prices are flat after marching higher yesterday after Energy Department data showed a bigger-than-expected 6.4 million decline in domestic stockpiles. The stock market erased most of this week’s losses, on Wednesday, eyeing a low-volume trading day today for Yom Kippur as some investors and traders leaving early. The S&P 500 rose +0.9% and Dow a +0.7% climb and the Nasdaq rose +0.8%, snapping its 5-day losing streak. Ten out of eleven S&P sectors were higher led by Energy. Market Closing Prices Yesterday · The S&P 500 Index gained 37.65 points, or 0.85%, to 4,480.70 · The Dow Jones Industrial Average rose 236.82 points, or 0.68%, to 34,814.39 · The Nasdaq Composite surged 123.77 points, or 0.82%, to 15,161.53 · The Russell 2000 Index advanced 24.46 points, or 1.11% to 2,234.45 Events Calendar for Today · 8:30 AM ET Weekly Jobless Claims…est. 330K · 8:30 AM EST Continuing Claims…est. 2.785M · 8:30 AM ET Philly Fed Index for September…est. 18.8 · 8:30 AM ET Retail Sales MoM for Aug…est. (-0.8%) · 8:30 AM ET Retail Sales Ex: Autos MoM for Aug…est. (-0.1%) · 10:00 AM ET Business Inventories MoM for July…est. +0.5% · 10:30 AM ET Weekly EIA Natural Gas Inventory Data · 4:00 PM ET Net Long-term TIC Flows for July Earnings Calendar: · Earnings Before the Open: IPHI, LMNX · Earnings After the Close: HRB Other Key Events: · Citigroup Small/Mid-Cap & Growth Conference 2021 (virtual), 9/16-9/17 · European Society for Medical Oncology (ESMO) 2021 Virtual Congress, 9/16-9/21 World News · The United States, Britain and Australia announced a new security partnership for the Indo-Pacific in a move hailed by regional allies but denounced by China as intensifying an arms race in the region. Under the partnership, announced by President Joe Biden, British Prime Minister Boris Johnson and Australian Prime Minister Scott Morrison, the United States and Britain will provide Australia with the technology and capability to deploy nuclear-powered submarines. · US House Ways and Means Committee votes to advance plan to raise taxes on wealthy Americans and corporations as part of Democrats’ reconciliation spending bill Sector News Breakdown Consumer · Beyond Meat (BYND) downgraded to Underweight from Neutral with a price target of $95, down from $120 at Piper saying the company’s current all-channel retail momentum will lag consensus expectations and foodservice consensus estimates may be high · AMC Entertainment (AMC) CEO Aron said yesterday that AMC Theatres will accept Bitcoin for online ticket and concession payments, and similarly accept other cryptocurrencies like Ethereum, Litecoin and Bitcoin Cash. · Callaway Golf ($ELY) 4M share Secondary priced at $29.25 · Figs ($FIGS) 8.92M share Secondary priced at $40.25 · Molson Coors Beverage Co. ($TAP) said it plans to expand distribution of its Topo Chico Hard Seltzer nationwide, starting January 2022 · China’s leading ride-hailing app, Didi ($DIDI), has seen its daily users fall by 30% since its initial public offering in New York in June triggered a fierce backlash by Beijing, the Financial Times reported. https://on.ft.com/2XmIqy8 · Laureate Education, Inc. ($LAUR) said its Board approved a plan of partial liquidation (the “Plan”) in connection with the previously disclosed sale of Walden e-Learning LLC Energy, Industrials and Materials · Timken ($TKR) said it expects lower sales and earnings in second half of 2021; said underlying customer demand and end-market momentum remain strong across most sectors and expects a robust industrial market environment for remainder of 2021 and throughout 2022 · Ion Geophysical ($IO) announced that its board of directors has initiated a process to evaluate a range of strategic alternatives in an effort to strengthen its financial position and maximize stakeholder value · Pioneer Natural Resources ($PXD) increased its 2030 goals to a 50% reduction in GHG intensity and a 75% reduction in methane intensity from 2019 baseline · Sibanye Stillwater ($SBSW) agrees to acquire half of Ioneer Ltd.’s Nevada lithium project for $490M – Reuters · The Association of American Railroads reports total weekly US rail traffic down 1.3% Y/Y to 468,610 carloads and intermodal units for the week ending September 11, 2021; Carloads up 4.5% to 223,710; intermodal volume down 6% to 244,900 containers · SpaceX successfully launched four civilians into space Wednesday evening in the first spaceflight staffed wholly by commercial astronauts, which is not a government-backed crew to orbit Earth. The aerospace company run by Elon Musk launched the crew of Inspiration4 from NASA’s Kennedy Space Center shortly after 8 p.m. ET on Wednesday. The mission will take the four astronauts 360 miles from Earth for at least three days before they splash down in one of several spots off the Florida coast. Financials · Enact Holdings ($ACT) 13.31M share IPO priced at $19.00 · Veritex ($VBTX) boosts share buyback to $250M from $175M Healthcare · Aerie Pharmaceuticals ($AERI) shares fall -19%; a Phase 2b study of the company’s experimental treatment for dry eye disease failed to meet the main goal of the trial · Exelixis ($EXEL) announces results from Phase 3 CheckMate -9ER trial demonstrating efficacy benefits regardless of prior nephrectomy status with Cabometyx (cabozantinib) in combination with Bristol Myers Squibb’s (BMY) Opdivo (nivolumab) vs. sunitinib for patients with previously untreated advanced renal cell carcinoma (RCC). · Moderna ($MRNA) said a study of breakthrough COVID-19 cases among vaccinated individuals supports the need for a booster shot. Moderna identified 88 breakthrough COVID cases among 11,431 people vaccinated between December 2020 and March 2021, but 162 cases in the group who got their shots between July and October of last year. · Travere Therapeutics ($TVTX) reported a joint collaboration and licensing agreement with Vifor Pharma for the commercialization of Sparsentan in Europe, Australia and New Zealand · BioXcel Therapeutics ($BTAI) presents results from ongoing phase 2 trial of BXCL701 in combination with KEYTRUDA® in aggressive forms of prostate cancer at ESMO · The FDA has decided not to take a stand on the efficacy of a booster shot from Pfizer ($PFE), as the agency says it doesn’t have enough data to make a decision, and that it’s only seen an observational study in Israel. · Invitae Corp ($NVTA) files for stock shelf of up to 6.3 mln common shares by the selling stockholders · Takeda’s ($TAK) EXKIVITY™ (mobocertinib) approved by U.S. FDA as the first oral therapy specifically designed for patients with EGFR Exon20 Insertion+ NSCLC Technology, Media & Telecom · Electronic Arts ($EA) announces Battlefield 2042 is now set to launch worldwide on November 19, 2021 (shares of EA fell yesterday on talk it might have been delayed into 2022, but launch also a month later than originally expected); reiterating net bookings guidance for fiscal year 2022 provided on august 4, 2021, despite this change in launch date for Battlefield 2042 · Cisco ($CSCO) upgraded to Outperform from Neutral at Credit Suisse at Credit Suisse · ForgeRock ($FORG) 11M share IPO priced at $25.00 · Texas Instruments ($TXN) raises quarterly dividend 13% to $1.15 from $1.02 per share · Adobe ($ADBE) announced the upcoming availability of Payment Services for Adobe Commerce, “the industry’s leading end-to-end commerce application for B2B, D2C and hybrid use cases · InterDigital ($IDCC) sees Q3 revenue $119M-$121M vs. est. $111.64M, driven by both an expected $15M of recurring revenue and $30M of non-recurring revenue from a fixed price license agreement signed during Q

66 Replies 13 👍 7 🔥

profile
@DarkPoolAlgo #Dark Pool Charts
recently

Tuesday, August 10, 2021 Futures Up/Down % Last Dow -19.00 0.05% 34,979 S&P 500 -0.25 0.02% 4,425 Nasdaq 17.50 0.12% 15,142 Stock markets are looking quiet again, as major averages have been holding near record highs but struggling for direction to start the week. Stronger economic data last Friday on the form of non-farm payrolls and declining unemployment helped boost sentiment about the economy, overshadowing any uncertainty over what impact the fast-spreading delta virus variant will have on the economy and comments from Federal Reserve officials about scaling back support. In Asian markets, The Nikkei Index gained 68 points to settle at 27,888, the Shanghai Index jumped 35 points to 3,529, and the Hang Seng Index gained 322 points (1.23%) to close at 26,605. In Europe, the German DAX is up around 25 points to 15,770, while the FTSE 100 is down a few points at 7,125. Today a fairly busy day of economic data, but all eyes fixed on the inflation reports coming up tomorrow (CPI) and on Thursday (PP), to see if the four-month spike in prices is indeed transitory as the Fed has pledged or if it is something more troubling for consumers down the line. Earnings season has begun to slow, with nearly 450 S&P companies having reported this quarter, with only some big retailers (WMT, TGT, HD, LOW) remaining. Trading ranges have remained in tight ranges of late, as summer doldrums have kicked in early. Market Closing Prices Yesterday The S&P 500 Index slipped -4.17 points, or 0.09%, to 4,432.35 The Dow Jones Industrial Average fell -106.66 points, or 0.30%, to 35,101.85 The Nasdaq Composite gained 24.42 points, or 0.16%, to 14,860.18 The Russell 2000 Index declined -12.95 points, or 0.58% to 2,234.81 Events Calendar for Today 6:00 AM ET NFIB Small Business Optimism for July 7:45 AM ET ICSC Weekly Retail Sales 8:30 AM ET Non-farm Productivity, prelim-Q2 8:30 AM ET Unit Labor Costs, prelim-Q2 8:55 AM ET Johnson/Redbook Weekly Sales 1:00 PM ET U.S. to sell $58 bln in 3-year notes 4:30 PM ET API Weekly Inventory Data Earnings Calendar: Earnings Before the Open: BSY, BTAI, CSPR, FULC, GTIM, IIVI, JBI, KPLT, LAND, LODE, MRNSD, MTNB, NAUT, OWL, SMID, SYY, TDG, TDW, VITL, VPG, VSH, VTNR Earnings After the Close: AIRG, AVGR, BVS, CHK, CLSD, COIN, COKE, CSSE, CURI, DAR, DOCS, EPAY, FTEK, GO, HCKT, HYRE, JAMF, KODK, KTCC, LPRO, LRN, MCFE, MEG, NARI, NVEE, OPFI, PANL, PAY, PAYS, PLBY, POSH, PUBM, SFT, SIEN, SMCI, TASK, TDUP, U, UPST, VEC, WW, ZETA Other Key Events: BTIG Biotechnology Conference 2021 (virtual), 8/9-8/10 Canaccord Genuity 41st Annual Growth Conference (virtual), 8/10-8/12 Cowen Annual Communications Infrastructure Hybrid Summit, 8/9-8/12 Cowen 9th Annual Internet & Media Bus Tour (virtual), 8/9-8/13 KeyBanc Capital Markets Technology Leadership Virtual Forum, 8/9-8/12 Oppenheimer 24th Annual Technology, Internet & Comm Conference (virtual), 8/10-8/12 Piper Biotech Virtual Tour, 8/10-8/12 Susquehanna 2021 Energy, Industrials & Airlines Conference (virtual), 8/10-8/11 UBS Financial Services Conference (virtual), 8/10-8/12 Wells Fargo 6th Annual FinTech & Technology Services Forum (virtual), 8/10-8/11 Macro Up/Down Last Nymex 1.05 67.51 Brent 0.84 69.88 Gold -1.00 1,728.90 EUR/USD -0.0018 1.1719 JPY/USD 0.24 110.53 10-Year Note +0.002 1.319% World News The NFIB Small Business Optimism Index was 99.7 vs. 103.3 consensus, and down from 102.5 in June. Germany Aug ZEW Sentiment4, well below the 56.7 consensus; conditions 29.3 vs 30.0 consensus; expectations decline for third time in a row; concerns over 4th wave of COVID affecting German economy in the Autumn Sector News Breakdown Consumer AMC Entertainment ($AMC) Q2 adj EPS loss (-$0.71) vs. est. loss (-$0.93); Q2 revs $444.7M vs. est. $381.28M; currently has liquidity availability of more than $2.0 billion; said welcomed more than 22 million guests back to theatres during Q2; said as of June 30, 2021, operated 593 domestic theatres & 335 international theatres Calloway ($ELY) 2Q adj EPS $0.36 vs est. $0.01 on revs $914Mm vs est. $753.1Mm; guides 3Q revs $775-790Mm vs est. $763Mm, sees 3Q adj EBITDA $51-58Mm vs est. $77.3Mm; guides FY revs $3.025-3.055B vs est. $2.84B, sees FY adj EBITDA $345-360Mm vs est. $295.3Mm CarLotz ($LOTZ) 2Q EPS ($0.06) vs est. ($0.20) on revs $50.8Mm vs est. $48.1Mm; withdraws previous FY21 outlook due to channel constraints Chegg Inc. ($CHGG) 2Q adj EPS $0.43 vs est. $0.37 on revs $198.5Mm vs est. $190.1Mm; guides 3Q revs $170-175Mm vs est. $173Mm; guides FY21 revs $805-815Mm vs est. $797.8Mm, sees FY adj EBITDA $295-300Mm vs est. $278.6Mm DoorDash ($DOOR) 2Q adj EPS $2.23 vs est. $2.09 on revs $662Mm vs est. $635.2Mm; guides FY sales +17-20% vs est. +14.5%, sees FY adj EPS $8.00-8.60 vs est. $8.50 Inter Parfums ($IPAR) 2Q EPS $0.71 vs est. $0.43 on revs $207.6Mm vs est. $207.6m; continues to see FY revs approx $750Mm vs est. $758.1Mm, EPS $1.95 vs est. $1.93 Nautilus ($NLS) Q1 EPS $0.43 vs. est. $0.30; Q1 revs $185M vs. est. $169.05M; said Q1 retail grew sales by 91% or 107% excluding Octane, delivering record net sales of $120 million, while Direct grew by 26%; sees Q2 revs $145M-$155M vs. est. $153.05M Original BARK ($BARK) 1Q adj EPS ($0.09) vs est. ($0.06) on revs $117.6Mm vs est. $116.8Mm; guides 2Q revs $122Mm vs est. $120.3Mm; reaffirms FY guide, sees FY revs $516Mm vs est. $516.5Mm Plant Fitness ($PLNT) Q2 adj EPS $0.21 vs. est. $0.23; Q2 revs $137.3M vs. est. $127.2M; ends second quarter with total membership of more than 14.8M and over 98% of stores open globally; Q2 adj EBITDA increased $64.8M to $55.6M from a loss of $9.3M in the prior year period; sees FY21 adj EPS $0.65-$0.70 vs. est. $0.94; sees FY21 revs $530M-$540M vs. est. $541.69M Purple Innovation ($PRPL) Q2 adj EPS $0.05 vs. est. $0.12; Q2 revs $182.6M vs. est. $181.8M; guides year revs $820M-$850M vs. est. $823.6M; sees year Ebitda $78M-$88M vs. est. $81.8M RealReal inc. ($REAL) Q2 EPS loss (-$0.50) vs. est. (-$0.47); Q2 revs $104.91M vs. est. $107.25M; Q2 GMV $350M; said trailing 12 months active buyers reached 730,000, an increase of 19% year-over-year and 48% compared to the same period in 2019; Orders reached 673K, an increase of 53% Y/Y and 33% compared to the same period in 2019. Tesla ($TSLA) sold 32,968 China-made vehicles in July, including 24,347 for export, the China Passenger Car Association (CPCA) said on Tuesday; local sales of China-made vehicles plunged 69% to 8,621 cars from 28,138 in June. Financials First Republic ($FRC) announces offering of 2M shares of common stock CoreCivic ($CXW) Q2 adj FFO $0.46; Q23 revs $464.6M vs. est. $466.1M; Adjusted EBITDA of $101.7M; sale of five non-core real estate assets for gross proceeds of $328.7 million SVB Financial ($SIVB)23M share Spot Secondary priced at $564.00 P. Carey ($WPC) 4.5M share Spot Secondary priced at $78.00 Healthcare BioCryst ($BCRX) announces offering of $200M of common stock, warrants Halozyme ($HALO) Q2 non-GAAP EPS $0.66 vs. est. $0.40; Q2 revs $136.5M vs. est. $103.16M; raises FY21 non-GAAP EPS view to $1.85-$2.00 from $1.55-$1.70 and boosts FY21 revenue view to $425M-$445M from $375M-$395M (est. $404.5M) citing the recent signing of a new collaboration and license agreement and strong year-to-date results Inovio Pharma ($INO) 2Q EPS ($0.39) vs est. ($0.25) on revs $273K; as of June 30, cash and equivalents & s-t investments were $443.7Mm, says continue to evaluate and assess impact of new covid strains Penumbra ($PEN) 2Q adj EPS $0.21 vs est. $0.17 on revs $184.3Mm vs est. $170.8Mm; guides FY revs $720-730Mm vs est. $702.7Mm Reta Pharma ($RETA) 2Q adj EPS ($1.32) vs est. ($2.06); reaffirms cash runway through mid-2024, reaffirms plan to submit MAA with EMA in 4Q21 for marketing approval of bardoxolone for treatment of CKD Rocket Pharma ($RCKT) Q2 EPS loss (-$0.55); expects its balance in cash equivalents and investments of $426.8 mln as of June 30, to fund its operations into 2H 2023 Shockwave Medical ($SWAV) Q2 EPS loss (-$0.01) vs. est. loss (-$0.41); Q2 revs $55.908M vs. est. $45.17M; raises FY21 revenue view $218M-$223M from $195M-$205M (est. $200.6M); Granted approval for a Transitional Pass-Through (TPT) payment for Shockwave C2 Coronary IVL device, which became effective July 1, 2021 for procedures in the outpatient setting SmileDirectClub ($SDC) 2Q EPS ($0.14) vs est. ($0.09) on revs $174Mm vs est. $198.5Mm; guides FY revs $750-800Mm vs est. $833.6Mm; Q2 average aligner gross sales price of $1,885 for Q2, compared to $1,817 for the second quarter of 2020 Steris Plc ($STE) Q1 adj EPS $1.76 vs. est. $1.49; Q1 revs $968.4M vs. est. $904.9M; now expects as reported revenue of approximately $4.6B in 2022, an increase from prior expectations of $4.5B; sees year EPS $7.60-$7.85 vs. est. $7.51; free cash flow for fiscal 2022 is now expected to be approximately $400 mln; raises dividend

59 Replies 13 👍 15 🔥

profile
@DarkPoolAlgo #Dark Pool Charts
recently

Wednesday, June 23, 2021 Futures Up/Down % Last Dow 50.00 0.15% 33,885 S&P 500 2.50 0.06% 4,239 Nasdaq 14.75 0.10% 14,273 Markets are looking modestly higher in the U.S., tracking gains in Europe and Asia as investors appear at ease over the inflation picture after Federal Reserve Chairman Powell reiterated yesterday in testimony to Congress that a spike in inflation likely was temporary, easing worries that the central bank could pull back on economic support. Stocks closed higher on Tuesday as the Nasdaq posted a record closing high, boosted by shares of large cap tech as Amazon, Microsoft, and Apple paced the gains in a further rotation into growth stocks. Amazon produced over $5.6 billion in total online sales in the United States on the first day of its Prime promotional event, according to Adobe Digital Economy Index. Helping boost markets further, Federal Reserve Chair Jerome Powell reaffirmed the U.S. central bank’s view during his testimony to Congress on the U.S. economy to not to raise interest rates too quickly based on the fear of coming inflation. Most of the 11 major S&P sector indexes rose, with consumer discretionary and energy among the biggest gainers, erasing most of last week’s market declines. In Asian markets, The Nikkei Index slipped -9 points to 28,874, the Shanghai Index rose 8 points to 3,566, and the Hang Seng Index jumped 507 points to 28,817. In Europe, the German DAX is down -75 points to 15,560, while the FTSE 100 is up 20 points to 7,110. Oil rises back above $75 as API weekly data shows stockpiles drop/shows tight market; Bitcoin rebounds 7% to $34,000, a more than $5,000 move off yesterday lows, having plunged more than 50% from its all-time highs above $65,000 in mid-April; Treasury yields remains little changed/tight range as 10-year at 1.475%. Market Closing Prices Yesterday The S&P 500 Index gained 21.65 points, or 0.51%, to 4,246.44 The Dow Jones Industrial Average rose 68.61 points, or 0.20%, to 33,945.58 The Nasdaq Composite jumped 111.79 points, or 0.79%, to 14,253.27 The Russell 2000 Index advanced 111.79 points, or 0.43% to 2,295.95 Events Calendar for Today 7:00 AM ET MBA Mortgage Applications Data 9:45 AM ET Markit Composite flash PMI, June 9:45 AM ET Markit Manufacturing Services PMI, June…est. 61.5 10:00 AM ET New Home Sales MoM for May…est. 870K 10:30 AM ET Weekly DOE Inventory Data Earnings Calendar: Earnings Before the Open: $PDCO, $WGO Earnings After the Close: $CNXC, $FUL, $KBH, $SCS Other Key Events: BMO Capital 2021 Chemical & Packaging Conference (virtual), 6/23 Goldman Sachs 17th Business Services, Transport & Leisure Conference (virtual), 6/21-6/23 Raymond James Human Health Innovation Conference (virtual), 6/21-6/23 Roth London Conference (virtual), 6/21-6/23 Jefferies Consumer Conference (virtual), 6/22-6/23 JPMorgan 2021 Energy, Power & Renewables Conference (virtual), 6/22-6/23 JPMorgan Payment & FinTech Forum (virtual), 6/23-6/24 Sidoti Investor Conference (virtual), 6/23-6/24 Macro Up/Down Last Nymex 0.45 73.30 Brent 0.55 75.36 Gold 4.30 1,783.005 EUR/USD 0.0006 1.1946 JPY/USD 0.34 110.99 10-Year Note +0.003 1.475% Sector News Breakdown Consumer Xpeng ($XPEV) shares rise upon on receiving approval to list on Hong Kong stock exchange; the company could raise as much as $2B in Hong Kong as soon as this year Energy, Industrials and Materials The American Petroleum Institute ($API) showed a draw of 7.2M barrels of oil in the latest week, gasoline inventories show a build of 959K barrels, distillate inventories show a build of 992K barrels and Cushing inventories show a draw of 2.55M barrels. Clean Energy Fuels ($CLNE) said it contributed $50M to its 50-50 joint venture with BP Plc ($BP) and forced the conversion of BP’s Class B units into Class A units. Parker-Hannifin (PH) upgraded to Overweight from Sector Weight at KeyBanc United Rentals ($URI) upgraded to Buy from Neutral at Citi Financials IHS Markit ($INFO) Q2 adj EPS 81c vs. est. 80c; Q2 revs $1.18B vs. est. $1.13B; raises FY21 adjusted EPS view to $3.15-$3.17 from $3.11-$3.16 (est. $3.16), ups FY21 revenue view to $4.635B-$4.675B from $4.535B-$4.635B (est. $4.6B) and boosts FY21 adj EBITDA view to $2.02B-$2.03B from $2B-$2.03B Global Self Storage ($SELF)12M share Spot Secondary priced at $5.35 Intercontinental Exchange ($ICE) upgraded to Conviction Buy from Buy at Goldman Sachs LPL Financial ($LPLA) downgraded to Buy from Conviction Buy at Goldman Sachs Healthcare BioXcel Therapeutics Inc ($BTAI) launches $100M stock offering with $15M overallotment option on behalf of related stockholder Enanta Pharmaceuticals ($ENTA) says announced positive data from the first two dose cohorts of its Phase 1b study of EDP-514 in viremic chronic HBV patients who were not being treated with a nucleoside reverse transcriptase inhibitor Gemini Therapeutics ($GMTX) announces initial data from its ongoing phase 2a study of gem103 in patients with geographic atrophy secondary to dry age-related macular degeneration GlaxoSmithKline PLC ($GSK) said that it expects growth in sales and adjusted operating profit over the next five years to be underpinned by new vaccines and specialty medicines, as it set targets for the medium and l-t following planned 2022 demerger of its consumer healthcare business. Hologic ($HOLX) has received CE mark for its new Aptima CMV Quant assay in Europe, the company announced United Therapeutics Corp. ($UTHR) and Medtronic Inc. ($MDT) have agreed to stop further efforts to develop and commercialize the implantable system for Remodulin, or ISR; the companies plan to wind down the development program and to support patients already enrolled in clinical studies of the ISR at United Therapeutics’ sole expense Second Sight ($EYES) 10M share Spot Secondary priced at $5.00 Teva Pharmaceuticals ($TEVA) announced its U.S. launch of the first generic version of twice daily PERFOROMIST, formoterol fumarate inhalation solution, 20 mcg/2 ML, indicated to treat bronchoconstriction in patients with chronic obstructive pulmonary disease, including chronic bronchitis and emphysema Technology, Media & Telecom Intel Corp. ($INTC) said it would create two new business units that would focus separately on software and high-performance computing and graphics; also said current executives Sandra Rivera and Raja Koduri will take on new senior leadership roles, while technology industry veterans Nick McKeown and Greg Lavender will join Intel. Corning ($GLW) said midday yesterday it is increasing its display glass substrate prices for Q3 “moderately” due to higher logistics and materials costs and other operational expenses during the extended glass shortage Bentley Systems ($BSY) announces offering of $500M of convertible senior notes Sprinklr ($CXM)625M share IPO priced at $16.00

40 Replies 12 👍 10 🔥

profile
@Snowcow #droscrew
recently

$btai quite a tank there

124 Replies 10 👍 6 🔥

profile
@CarlosH-carvan #ivtrades
recently

$BTAI raised to $175.00

42 Replies 15 👍 13 🔥

profile
@dros #droscrew
recently

BTAI apparently the only stock with IV left lol

109 Replies 6 👍 12 🔥

profile
@Navneet #droscrew
recently

btai expiry ?

136 Replies 14 👍 10 🔥

profile
@RedSunCap #droscrew
recently

226 $BTAI 65 calls trade 5.90

75 Replies 8 👍 7 🔥

profile
@RedSunCap #droscrew
recently

226 $BTAI 65 calls trade 5.90

98 Replies 7 👍 14 🔥

profile
@RedSunCap #droscrew
recently

damn look at this $BTAI

81 Replies 12 👍 11 🔥

Key Metrics

Market Cap

322.95 M

Beta

1.72

Avg. Volume

574.14 K

Shares Outstanding

27.99 M

Yield

0%

Public Float

0

Next Earnings Date

2022-08-10

Next Dividend Date

Company Information

BioXcel Therapeutics, Inc. is a clinical-stage biopharmaceutical company utilizing artificial intelligence approaches to develop transformative medicines in neuroscience and immuno-oncology. BioXcel's drug re-innovation approach leverages existing approved drugs and/or clinically validated product candidates together with big data and proprietary machine learning algorithms to identify new therapeutic indices. BioXcel's two most advanced clinical development programs are BXCL501, an investigational, proprietary, orally dissolving thin film formulation of dexmedetomidine for the treatment of agitation and opioid withdrawal symptoms, and BXCL701, an investigational, orally administered, systemic innate immunity activator in development for the treatment of aggressive forms of prostate cancer and advanced solid tumors that are refractory or treatment naïve to checkpoint inhibitors.

CEO: Vimal Mehta

Website:

HQ: 555 Long Wharf Dr New Haven, 06511-6107 Connecticut

Related News